Philip Berardi

537 total citations
22 papers, 366 citations indexed

About

Philip Berardi is a scholar working on Hematology, Physiology and Molecular Biology. According to data from OpenAlex, Philip Berardi has authored 22 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 9 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Philip Berardi's work include Blood groups and transfusion (7 papers), Erythrocyte Function and Pathophysiology (6 papers) and Acute Myeloid Leukemia Research (4 papers). Philip Berardi is often cited by papers focused on Blood groups and transfusion (7 papers), Erythrocyte Function and Pathophysiology (6 papers) and Acute Myeloid Leukemia Research (4 papers). Philip Berardi collaborates with scholars based in Canada, United States and Australia. Philip Berardi's co-authors include Karl Riabowol, Michael W. Russell, Wei Gong, Karl‐Heinz Krause, Anis Féki, Irmgard Irminger‐Finger, Charles Edward Jefford, Laetitia Cartier, Tracy Morrison and Ronald A. Booth and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Philip Berardi

20 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Berardi Canada 10 248 86 54 51 43 22 366
Rositsa Koleva United States 6 213 0.9× 66 0.8× 14 0.3× 25 0.5× 46 1.1× 7 314
Marion Leick Germany 8 98 0.4× 172 2.0× 35 0.6× 21 0.4× 17 0.4× 11 416
Ana Rita Lourenço Netherlands 9 238 1.0× 90 1.0× 19 0.4× 13 0.3× 106 2.5× 11 383
Rachid Lahlil France 8 239 1.0× 66 0.8× 59 1.1× 96 1.9× 24 0.6× 20 375
Mark D. Roycik United States 10 150 0.6× 134 1.6× 18 0.3× 27 0.5× 167 3.9× 10 368
Iris Kufferath Austria 8 265 1.1× 68 0.8× 14 0.3× 13 0.3× 45 1.0× 11 396
Kristen Bisanz United States 6 287 1.2× 124 1.4× 32 0.6× 18 0.4× 58 1.3× 7 389
Isabella Spinello Italy 12 320 1.3× 59 0.7× 15 0.3× 102 2.0× 248 5.8× 15 492
Dorine Wouters Netherlands 9 122 0.5× 111 1.3× 54 1.0× 25 0.5× 61 1.4× 9 377

Countries citing papers authored by Philip Berardi

Since Specialization
Citations

This map shows the geographic impact of Philip Berardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Berardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Berardi more than expected).

Fields of papers citing papers by Philip Berardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Berardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Berardi. The network helps show where Philip Berardi may publish in the future.

Co-authorship network of co-authors of Philip Berardi

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Berardi. A scholar is included among the top collaborators of Philip Berardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Berardi. Philip Berardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lieberman, Lani, Valérie Arsenault, Philip Berardi, et al.. (2023). The selection and preparation of red cell components for intrauterine transfusion: A national survey. Vox Sanguinis. 119(3). 265–271. 1 indexed citations
2.
Bergeron, Julie, José‐Mario Capo‐Chichi, Hubert Tsui, et al.. (2023). The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current Oncology. 30(12). 10410–10436. 4 indexed citations
4.
Vege, Sunitha, et al.. (2021). An intron c.149‐2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype. Transfusion. 62(2). E14–E16. 3 indexed citations
5.
Parlow, Simon, Matthew C. Cheung, Philip Berardi, et al.. (2021). An Unusual Case of Obstructive Shock. JACC Case Reports. 3(18). 1913–1917. 1 indexed citations
6.
Berardi, Philip, et al.. (2020). Anaplastic large cell lymphoma as a posttransplant lymphoproliferative disorder in a renal transplant patient: A case report. SHILAP Revista de lepidopterología. 1(1). 364–367. 1 indexed citations
7.
Shih, Andrew W., Matthew Yan, Rebecca Barty, et al.. (2020). Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk‐stratify patients for alloimmunisation risk. Transfusion Medicine. 30(4). 263–274. 5 indexed citations
8.
Morrison, Tracy, Ronald A. Booth, Kristin Hauff, Philip Berardi, & Alissa Visram. (2019). Laboratory assessment of multiple myeloma. Advances in clinical chemistry. 89. 1–58. 30 indexed citations
10.
Clarke, Gwen, Judith Hannon, Philip Berardi, et al.. (2016). Resolving variable maternal D typing using serology and genotyping in selected prenatal patients. Transfusion. 56(12). 2980–2985. 9 indexed citations
11.
Berardi, Philip, et al.. (2015). Weak D type 67 in four related Canadian blood donors. Immunohematology. 31(4). 159–162. 1 indexed citations
12.
Padmore, Ruth, Philip Berardi, Antonio Giulivi, et al.. (2014). Acute extravascular hemolytic transfusion reaction due to anti-Kpa antibody missed by electronic crossmatch. Transfusion and Apheresis Science. 51(2). 168–171. 5 indexed citations
13.
Berardi, Philip, Nathaniel Bouganim, Lisa Vandermeer, et al.. (2012). Excision of the Primary Tumour in Patients with Metastatic Breast Cancer: A Clinical Dilemma. Current Oncology. 19(4). 270–279. 11 indexed citations
14.
Féki, Anis, Philip Berardi, Geoff Bellingan, et al.. (2009). Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model. Critical Reviews in Oncology/Hematology. 72(1). 1–9. 47 indexed citations
15.
Soliman, Mohamed A., et al.. (2008). ING1a expression increases during replicative senescence and induces a senescent phenotype. Aging Cell. 7(6). 783–794. 46 indexed citations
16.
Han, Xijing, Philip Berardi, & Karl Riabowol. (2006). Chromatin Modification and Senescence: Linkage by Tumor Suppressors?. Rejuvenation Research. 9(1). 69–76. 15 indexed citations
17.
Russell, Michael W., Philip Berardi, Wei Gong, & Karl Riabowol. (2006). Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. Experimental Cell Research. 312(7). 951–961. 92 indexed citations
18.
Féki, Anis, Charles Edward Jefford, Philip Berardi, et al.. (2005). BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase. Oncogene. 24(23). 3726–3736. 60 indexed citations
19.
Berardi, Philip, Michael W. Russell, Assam El‐Osta, & Karl Riabowol. (2004). DNA damage repair and transcription. Cellular and Molecular Life Sciences. 61(17). 2173–80. 23 indexed citations
20.
Berardi, Philip, et al.. (2003). A Novel Transcriptional Inhibitory Element Differentially Regulates the Cyclin D1 Gene in Senescent Cells. Journal of Biological Chemistry. 278(9). 7510–7519. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026